These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11762360)

  • 1. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
    Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
    Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Kanakis G; Kaltsas G
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in neuroendocrine tumors.
    Eriksson B; Oberg K; Stridsberg M
    Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers in neuroendocrine tumours.
    Oberg K; Janson ET; Eriksson B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of neuroendocrine tumours.
    de Herder WW
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
    Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
    Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K
    Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
    Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
    J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biology and imaging of neuroendocrine tumors].
    Baudin E; Dromain C
    Rev Prat; 2002 Feb; 52(3):268-73. PubMed ID: 11925716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic polypeptide secreting endocrine pancreas tumor associated with multiple stomach and duodenal ulcers].
    Mehring UM; Jäger HJ; Klöppel G; Hasse FM
    Langenbecks Arch Chir; 1997; 382(3):134-7. PubMed ID: 9324611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
    Rehfeld JF
    Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
    Rindi G; Luinetti O; Cornaggia M; Capella C; Solcia E
    Gastroenterology; 1993 Apr; 104(4):994-1006. PubMed ID: 7681798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic endocrine tumors.
    Oberg K
    Semin Oncol; 2010 Dec; 37(6):594-618. PubMed ID: 21167379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Testing in Patients with Neuroendocrine Tumors.
    Granberg D
    Front Horm Res; 2015; 44():24-39. PubMed ID: 26303702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
    Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
    Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in neuroendocrine neoplasms.
    Zouli C; Zisimopoulou E; Chrisoulidou A
    Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors.
    Sclafani F; Carnaghi C; Di Tommaso L; Rodari M; Destro A; Rimassa L; Giordano L; Chiti A; Roncalli M; Santoro A
    Tumori; 2011; 97(5):620-8. PubMed ID: 22158494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.